Heron Therapeutics HRTX
$ 1.3
7.44%
Quarterly report 2024-Q3
added 11-12-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Barry Quart |
Employees in the company |
231 |
Shares |
138 M |
Market Cap[1] |
$ 180 M |
EBITDA (LTM) |
$ -124 M |
P/E (LTM) |
-4.61 |
P/S (LTM) |
1.32 |
EPS (LTM) |
-0.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.